The Utility of Health States After Stroke: A Systematic Review of the Literature

Background— To perform decision analyses that include stroke as one of the possible health states, the utilities of stroke states must be determined. We reviewed the literature to obtain estimates of the utility of stroke and explored the impact of the study population and the elicitation method. Summary of Review— We searched various databases for articles reporting empirical assessment of utilities. Mean utilities of major stroke (Rankin Scale 4 to 5) and minor stroke (Rankin Scale 2 to 3) were calculated, stratified by study population and elicitation method. Additionally, the modified Rankin Scale was mapped onto the EuroQol classification system. Utilities were obtained from 23 articles. Patients at risk for stroke assigned utilities of 0.26 and 0.55 to major and minor stroke, respectively. Stroke survivors assigned higher utilities to both major (0.41) and minor stroke (0.72). The EuroQol completed by stroke survivors revealed a utility of 0.32 and 0.71 for major and minor stroke, respectively. Utilities elicited by the Standard Gamble were generally higher, while those obtained by the Visual Analogue Scale were lower than the Time Trade Off values. Remaining variation between utilities may be caused by differences in definitions of the health states. The mapped EuroQol indicated a utility of 0.64 for minor stroke and a value just below zero for major stroke. Conclusions— For minor stroke, a utility between 0.50 and 0.70 seems to be reasonable for both decision analyses and cost-effectiveness studies. The utility of major stroke may range between 0 and 0.30 and may possibly be negative.

[1]  H. Schouten,et al.  Interobserver agreement for the assessment of handicap in stroke patients. , 1988, Stroke.

[2]  P. Glasziou,et al.  Quality of life six months after myocardial infarction treated with thrombolytic therapy , 1994, The Medical journal of Australia.

[3]  G. Naglie,et al.  Quality of life of stroke in younger individuals. Utility assessment in patients with arteriovenous malformations. , 1997, Stroke.

[4]  G W Torrance,et al.  Multi-attribute health status classification systems. Health Utilities Index. , 1995, PharmacoEconomics.

[5]  J. Lee,et al.  Patient Preferences for Stroke Outcomes , 1994, Stroke.

[6]  Tammy O. Tengs,et al.  One thousand health-related quality-of-life estimates. , 2000, Medical care.

[7]  D K Owens,et al.  The effect of stroke and stroke prophylaxis with aspirin or warfarin on quality of life. , 1996, Archives of internal medicine.

[8]  P. Duncan,et al.  Utilities for major stroke: results from a survey of preferences among persons at increased risk for stroke. , 1998, American heart journal.

[9]  D. Fryback,et al.  Toward consistency in cost-utility analyses: using national measures to create condition-specific values. , 1998, Medical care.

[10]  R. Califf,et al.  Stroke after thrombolysis. Mortality and functional outcomes in the GUSTO-I trial. Global Use of Strategies to Open Occluded Coronary Arteries. , 1995, Circulation.

[11]  R. Thomson,et al.  Decision analysis and guidelines for anticoagulant therapy to prevent stroke in patients with atrial fibrillation , 2000, The Lancet.

[12]  M. Weinstein,et al.  The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine. , 1996, JAMA.

[13]  D. Matchar,et al.  Depression and Other Determinants of Values Placed on Current Health State by Stroke Patients: Evidence From the VA Acute Stroke (VASt) Study , 2000, Stroke.

[14]  R. Bloch,et al.  Interobserver agreement for the assessment of handicap in stroke patients. , 1988, Stroke.

[15]  M. Gold Cost-effectiveness in health and medicine , 2016 .

[16]  A. House,et al.  Mood Disorders in the Year after First Stroke , 1991, British Journal of Psychiatry.

[17]  H. Sutherland Assessing patients' preferences. , 1995, Medical decision making : an international journal of the Society for Medical Decision Making.

[18]  J. Bamford,et al.  Classification and natural history of clinically identifiable subtypes of cerebral infarction , 1991, The Lancet.

[19]  A. Laupacis,et al.  Patient Preference-based Treatment Thresholds and Recommendations , 2000, Medical decision making : an international journal of the Society for Medical Decision Making.

[20]  P Sandercock,et al.  Are the modified “simple questions” a valid and reliable measure of health related quality of life after stroke? , 2000, Journal of neurology, neurosurgery, and psychiatry.

[21]  A M Stiggelbout,et al.  Patient preference for cancer therapy: an overview of measurement approaches. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  D K Owens,et al.  Cost-effectiveness of warfarin and aspirin for prophylaxis of stroke in patients with nonvalvular atrial fibrillation. , 1995, JAMA.

[23]  E. Cohen,et al.  Carotid Endarterectomy for Symptom-free Stenosis: The Patient's Point of View , 1994, Cardiovascular surgery.

[24]  P. Duncan,et al.  Defining post-stroke recovery: implications for design and interpretation of drug trials , 2000, Neuropharmacology.

[25]  R. Klein,et al.  The Beaver Dam Health Outcomes study , 1993, Medical decision making : an international journal of the Society for Medical Decision Making.

[26]  Milton C. Weinstein,et al.  The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine. , 1996 .

[27]  P. Dorman,et al.  Is the EuroQol a valid measure of health-related quality of life after stroke? , 1997, Stroke.

[28]  D. Feeny,et al.  Health Utilities Index Mark 3: evidence of construct validity for stroke and arthritis in a population health survey. , 2000, Medical care.

[29]  S. Slørdahl,et al.  Stroke unit treatment improves long-term quality of life: a randomized controlled trial. , 1998, Stroke.

[30]  C. Anderson,et al.  Predicting Survival for 1 Year Among Different Subtypes of Stroke Results From the Perth Community Stroke Study , 1994, Stroke.

[31]  S. Hallan,et al.  Quality of life after cerebrovascular stroke: a systematic study of patients’ preferences for different functional outcomes , 1999, Journal of internal medicine.

[32]  P. Dolan,et al.  Modeling valuations for EuroQol health states. , 1997, Medical care.

[33]  D. Feeny,et al.  Use of the Health Utilities Index with stroke patients and their caregivers. , 1997, Stroke.

[34]  M C Weinstein,et al.  The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine. , 1996, JAMA.

[35]  G W Torrance,et al.  Utility approach to measuring health-related quality of life. , 1987, Journal of chronic diseases.

[36]  D. Feeny,et al.  Multiattribute utility function for a comprehensive health status classification system. Health Utilities Index Mark 2. , 1996, Medical care.

[37]  A. Stiggelbout,et al.  Explaining Distortions in Utility Elicitation through the Rank-dependent Model for Risky Choices , 1995, Medical decision making : an international journal of the Society for Medical Decision Making.

[38]  J. O'Meara,et al.  A decision analysis of streptokinase plus heparin as compared with heparin alone for deep-vein thrombosis. , 1994, The New England journal of medicine.